Omeros Quarterly Income Statement
NASDAQ: OMERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Omeros revenue and earnings
In the quarter ended Jun 30, 2026, Omeros generated $28.5 million in revenue, up 0.0% from the same quarter a year earlier. Net income was $13.2 million, for a net margin of 46.4% versus a median of 566.7% in the prior 5 quarters. Gross margin was 97.2% and operating margin 0.3%.
Diluted earnings per share came in at $0.15.
Summary generated from market data by MetaCap's automated system. Methodology
Omeros income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.53M | 9.89M | — | — | 0 | 0 | — | — | — | — | — | — |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of Revenue | 798.00K | 587.00K | — | — | 0 | 0 | — | — | — | — | — | — |
| Gross Profit | 27.73M | 9.31M | — | — | 0 | 0 | — | — | — | — | — | — |
| Operating Expenses | 27.66M | 26.73M | — | — | 32.35M | 34.97M | — | — | — | — | — | — |
| Research & Development | 13.80M | 13.36M | 19.45M | 15.99M | 22.01M | 23.85M | 23.32M | 24.08M | 45.35M | 26.77M | 28.89M | 31.73M |
| Selling, General & Admin | 13.86M | 13.37M | 9.63M | 10.40M | 10.35M | 11.12M | 10.04M | 11.32M | 13.81M | 12.26M | 10.88M | 16.42M |
| Operating Income | 74.00K | -17.42M | -29.08M | -26.39M | -32.35M | -34.97M | -33.35M | -35.41M | -59.16M | -39.03M | -39.77M | -48.15M |
| Interest Expense | 7.58M | 5.89M | 8.73M | -13.36M | 15.00K | 3.65M | 3.18M | 4.05M | 9.21M | 8.23M | 7.06M | 7.92M |
| Pretax Income | 6.67M | 51.31M | — | — | -25.89M | -37.56M | — | — | — | — | — | — |
| Income Tax | 29.00K | 57.00K | — | — | 0 | 0 | — | — | — | — | — | — |
| Net Income | 13.23M | 56.06M | 86.45M | -30.92M | -25.42M | -33.46M | -31.36M | -32.23M | -56.04M | -37.18M | -9.07M | -37.75M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | -107.04% | — |
| EPS (Basic) | 0.18 | 0.78 | 1.43 | -0.47 | -0.43 | -0.58 | -0.54 | -0.56 | -0.97 | -0.63 | -0.15 | -0.60 |
| EPS (Diluted) | 0.15 | 0.62 | 1.43 | -0.47 | -0.43 | -0.58 | -0.54 | -0.56 | -0.97 | -0.63 | — | — |
| Shares Outstanding (Basic) | 72.13M | 71.92M | — | 66.26M | 58.59M | 58.06M | — | 57.95M | 57.94M | 58.80M | — | 62.86M |
| Shares Outstanding (Diluted) | 89.63M | 90.12M | — | — | 58.59M | 58.06M | — | — | — | — | — | — |
| EBITDA | 267.00K | -17.18M | -28.85M | -26.15M | -32.15M | -34.68M | -33.05M | -35.17M | -58.95M | -38.83M | -39.56M | -47.96M |
| Gross Margin | 97.20% | 94.07% | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 26.00% | -176.09% | — | — | — | — | — | — | — | — | — | — |
| Net Margin | 46.38% | 566.66% | — | — | — | — | — | — | — | — | — | — |
This table shows 12 quarterly periods of Omeros's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow OMER's reporting calendar. What is a income statement?